Connect your AI

Quest Diagnostics DGX Accounts Receivable

Accounts Receivable at other companies

Myriad GeneticsMYGN

$123.8M+2.8%

Labcorp HoldingsLH

$2.29B+7.8%

Opko HealthOPK

$79.64M-17.2%

NeoGenomicsNEO

$167.42M+10.7%

Exagen Inc.XGN

$15.77M+7.1%

Personalis, Inc.PSNL

$13.02M+18.7%

Other financials

Income statement

Revenue$2.9B+9.2%

Gross profit$942.0M+9.2%

Operating income$399.0M+15.3%

Net income$252.0M+14.5%

EPS (diluted)$2.24+15.5%

Balance sheet

Cash & equivalents$393.0M+109%

Total debt$6.4B-2.5%

Total equity$7.4B+6.3%

Total assets$16.7B+5.5%

Cash flow

Operating cash flow$278.0M-11.5%

CapEx$114.0M-2.6%

Free cash flow$164.0M-16.8%

Valuation

Market cap$23.46B+20.8%

Enterprise value$29.48B+15.7%

P/E22.9×+2.5×

P/S2.1×+0.2×

Profitability

Gross margin33.2%+0.4pp

Operating margin14.3%+0.6pp

Net margin9.1%+0.2pp

FCF margin11.8%+1.4pp

Returns & leverage

Return on equity14.3%+0.9pp

Debt / equity0.9×-0.1×

Current ratio1.2×-0.3×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Quest Diagnostics's accounts receivable?: Quest Diagnostics (DGX) reported accounts receivable of $1.59B in Q1 2026.
How has Quest Diagnostics's accounts receivable changed year-over-year?: Quest Diagnostics's accounts receivable increased by 13.0% year-over-year, from $1.4B to $1.59B.
What is the long-term trend for Quest Diagnostics's accounts receivable?: Over 5 years (2020 to 2025), Quest Diagnostics's accounts receivable has grown at a -1.5% compound annual growth rate (CAGR), from $1.52B to $1.41B.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.